Cargando…
Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy
Cancer metastasis is the leading cause of cancer-related death. Circulating tumor cells (CTCs) are shed into the bloodstream from either primary or metastatic tumors during an intermediate stage of metastasis. In recent years, immunotherapy has also become an important focus of cancer research. Thus...
Autores principales: | Zhong, Xiaoming, Zhang, Hangtian, Zhu, Ying, Liang, Yuqing, Yuan, Zhuolin, Li, Jiachen, Li, Jing, Li, Xin, Jia, Yifan, He, Tian, Zhu, Jiangyuan, Sun, Yu, Jiang, Wengting, Zhang, Hui, Wang, Cheng, Ke, Zunfu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982393/ https://www.ncbi.nlm.nih.gov/pubmed/31980023 http://dx.doi.org/10.1186/s12943-020-1141-9 |
Ejemplares similares
-
Clinical Significance of a Circulating Tumor Cell-based Classifier in Stage IB Lung Adenocarcinoma: A Multicenter, Cohort Study
por: Ren, Lijuan, et al.
Publicado: (2023) -
Nanostructure Embedded Microchips for Detection, Isolation,
and Characterization of Circulating Tumor Cells
por: Lin, Millicent, et al.
Publicado: (2014) -
Small-Molecule Targets in Tumor Immunotherapy
por: Zhu, Hui-Fang, et al.
Publicado: (2018) -
Polymer nanofiber-based microchips for EGFR mutation analysis of circulating tumor cells in lung adenocarcinoma
por: Jiang, Wenting, et al.
Publicado: (2018) -
Favorable response to immunotherapy in a pancreatic neuroendocrine tumor with temozolomide‐induced high tumor mutational burden
por: Cao, Yanshuo, et al.
Publicado: (2020)